DAVITA INC. (NYSE:DVA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 5, 2017, the Board of Directors (the “Board”) of DaVita Inc. (the “Company”) adopted resolutions expanding the Board from 11 to 12 members, and appointed Pascal Desroches, as a member of the Board, to fill the newly created seat on the Board.

Mr. Desroches will receive the standard compensation and indemnification applicable to all other non-employee directors. We have described our Non-Employee Director Compensation Policy in our Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 10, 2016. The form of indemnification agreement we entered into with Mr. Desroches is an exhibit to our Current Report on Form 8-K filed with the SEC on December 20, 2006.

No arrangement or understanding exists between Mr. Desroches and any other person or persons to which he was selected as a director. The Company has not been a participant in any transaction since the beginning of its last fiscal year, and is not a participant in any currently proposed transaction, in which Mr. Desroches, or any member of his immediate family, had or will have a direct or indirect material interest.

About DAVITA INC. (NYSE:DVA)

DaVita Inc., formerly DaVita HealthCare Partners Inc., is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.

DAVITA INC. (NYSE:DVA) Recent Trading Information

DAVITA INC. (NYSE:DVA) closed its last trading session up +0.08 at 65.79 with 647,638 shares trading hands.